NCT02435147 Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index Status COMPLETED Phase N/A
NCT02429882 Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis Status WITHDRAWN Phase PHASE2
NCT02425826 A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. Status COMPLETED Phase PHASE4
NCT02420587 AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) Status WITHDRAWN Phase PHASE2
NCT02415413 Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02415127 Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Status COMPLETED Phase PHASE3
NCT02412878 Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT02412306 Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT02411136 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02393859 Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE3
NCT02392559 Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders Status COMPLETED Phase PHASE3
NCT02392039 Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma Status TERMINATED Phase EARLY_PHASE1
NCT02391259 A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02384317 Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade Status COMPLETED Phase PHASE2
NCT02376790 Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02373813 Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission Status COMPLETED Phase PHASE3
NCT02366195 Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma Status COMPLETED Phase PHASE2
NCT02352753 Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI Status TERMINATED Phase PHASE3